SAO:PGMN3
Empreendimentos Pague Menos S.A. · SAO · Healthcare · BRL · FY for 2025
Figures on this page computed 2026-11-07 23:28 UTC
Last close
n/aBRL
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
6.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
1.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
-0.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
1.20Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
What it pays out is the furthest below its sector's middle: 0.17 against 0.54 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.72x
Its own average over 10 years, 8.65B.
- Profit2.37x
Its own average over 10 years, 109.9M.
- Free cash flow11.49x
Its own average over 10 years, -5.3M.
- Debt1.48x
Its own average over 10 years, 2.50B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 11.49 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 107.6 | 195.5 | 98.7 |
| 2018-12-31 | 112.7 | 222.9 | 98.7 |
| 2019-12-31 | 115.9 | -16.6 | 98.7 |
| 2020-12-31 | 123.7 | 230.2 | 108.2 |
| 2021-12-31 | 135.8 | 394.2 | 127.1 |
| 2022-12-31 | 165.8 | 632.0 | 123.6 |
| 2023-12-31 | 202.1 | 6.0 | 133.4 |
| 2024-12-31 | 228.1 | 247.1 | 164.7 |
| 2025-12-31 | 269.0 | 623.9 | 170.7 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
Figures behind the shape
Growth
16.8%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate16.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Five-year EPS growth rate10.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
One-year change in net income152.5%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Returns on capital
8.4%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity8.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets2.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
31.9%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin31.9%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin5.7%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin1.8%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-0.4%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
6.0xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings6.0x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
Price to book0.5x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA3.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.20safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity1.20
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.59
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage1.6x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score2.28
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
67.8%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Payout ratio67.8%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio-0.3x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.